R J Bailey1, D L Hay. 1. Proteomics & Biomedicine Research Group, School of Biological Sciences, University of Auckland, Auckland, New Zealand.
Abstract
BACKGROUND AND PURPOSE: Transmembrane proline (P) residues in family A G protein-coupled receptors (GPCRs) form functionally important kinks in their helices. These residues are little studied in family B GPCRs but experiments with the VPAC1 receptor and calcitonin receptor-like receptor (CL) show parallels with family A receptors. We sought to determine the function of these residues in the insert negative form of the human calcitonin receptor, a close relative of CL. EXPERIMENTAL APPROACH: Proline residues within the transmembrane domains of the calcitonin receptor (P246, P249, P280, P326, P336) were individually mutated to alanine (A) using site-directed mutagenesis. Receptors were transiently transfected into Cos-7 cells using polyethylenimine and salmon and human calcitonin-induced cAMP responses measured. Salmon and human calcitonin competition binding experiments were also performed and receptor cell-surface expression assessed by whole cell ELISA. KEY RESULTS: P246A, P249A and P280A were wild-type in terms of human calcitonin-induced cAMP activation. P326A and P336A had reduced function (165 and 12-fold, respectively). In membranes, human calcitonin binding was not detectable for any mutant receptor but in whole cells, binding was detected for all mutants apart from P326A. Salmon calcitonin activated mutant and wild-type receptors equally, although B(max) values were reduced for all mutants apart from P326A. CONCLUSIONS AND IMPLICATIONS: P326 and P336 are important for the function of human calcitonin receptors and are likely to be involved in generating receptor conformations appropriate for agonist binding and receptor activation. However, agonist-specific effects were observed , implying distinct conformations of the human calcitonin receptor.
BACKGROUND AND PURPOSE: Transmembrane proline (P) residues in family A G protein-coupled receptors (GPCRs) form functionally important kinks in their helices. These residues are little studied in family B GPCRs but experiments with the VPAC1 receptor and calcitonin receptor-like receptor (CL) show parallels with family A receptors. We sought to determine the function of these residues in the insert negative form of the humancalcitonin receptor, a close relative of CL. EXPERIMENTAL APPROACH: Proline residues within the transmembrane domains of the calcitonin receptor (P246, P249, P280, P326, P336) were individually mutated to alanine (A) using site-directed mutagenesis. Receptors were transiently transfected into Cos-7 cells using polyethylenimine and salmon and human calcitonin-induced cAMP responses measured. Salmon and human calcitonin competition binding experiments were also performed and receptor cell-surface expression assessed by whole cell ELISA. KEY RESULTS:P246A, P249A and P280A were wild-type in terms of human calcitonin-induced cAMP activation. P326A and P336A had reduced function (165 and 12-fold, respectively). In membranes, human calcitonin binding was not detectable for any mutant receptor but in whole cells, binding was detected for all mutants apart from P326A. Salmon calcitonin activated mutant and wild-type receptors equally, although B(max) values were reduced for all mutants apart from P326A. CONCLUSIONS AND IMPLICATIONS: P326 and P336 are important for the function of human calcitonin receptors and are likely to be involved in generating receptor conformations appropriate for agonist binding and receptor activation. However, agonist-specific effects were observed , implying distinct conformations of the humancalcitonin receptor.
Authors: K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano Journal: Science Date: 2000-08-04 Impact factor: 47.728
Authors: David R Poyner; Patrick M Sexton; Ian Marshall; David M Smith; Remi Quirion; Walter Born; Roman Muff; Jan A Fischer; Steven M Foord Journal: Pharmacol Rev Date: 2002-06 Impact factor: 25.468
Authors: Alessandro Bisello; Michael Chorev; Michael Rosenblatt; Luca Monticelli; Dale F Mierke; Serge L Ferrari Journal: J Biol Chem Date: 2002-07-09 Impact factor: 5.157
Authors: H H Versteeg; E Nijhuis; G R van den Brink; M Evertzen; G N Pynaert; S J van Deventer; P J Coffer; M P Peppelenbosch Journal: Biochem J Date: 2000-09-15 Impact factor: 3.857
Authors: Sarah Yohannan; Salem Faham; Duan Yang; Julian P Whitelegge; James U Bowie Journal: Proc Natl Acad Sci U S A Date: 2004-01-19 Impact factor: 11.205
Authors: Denise Wootten; John Simms; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton Journal: Proc Natl Acad Sci U S A Date: 2013-03-11 Impact factor: 11.205
Authors: James Barwell; Joseph J Gingell; Harriet A Watkins; Julia K Archbold; David R Poyner; Debbie L Hay Journal: Br J Pharmacol Date: 2012-05 Impact factor: 8.739
Authors: Shabana Vohra; Bruck Taddese; Alex C Conner; David R Poyner; Debbie L Hay; James Barwell; Philip J Reeves; Graham J G Upton; Christopher A Reynolds Journal: J R Soc Interface Date: 2012-12-12 Impact factor: 4.118
Authors: Harriet A Watkins; Madhuri Chakravarthy; Rekhati S Abhayawardana; Joseph J Gingell; Michael Garelja; Meenakshi Pardamwar; James M W R McElhinney; Alex Lathbridge; Arran Constantine; Paul W R Harris; Tsz-Ying Yuen; Margaret A Brimble; James Barwell; David R Poyner; Michael J Woolley; Alex C Conner; Augen A Pioszak; Christopher A Reynolds; Debbie L Hay Journal: J Biol Chem Date: 2016-03-24 Impact factor: 5.157
Authors: Michael J Woolley; Harriet A Watkins; Bruck Taddese; Z Gamze Karakullukcu; James Barwell; Kevin J Smith; Debbie L Hay; David R Poyner; Christopher A Reynolds; Alex C Conner Journal: J R Soc Interface Date: 2013-09-18 Impact factor: 4.118
Authors: Joseph J Gingell; John Simms; James Barwell; David R Poyner; Harriet A Watkins; Augen A Pioszak; Patrick M Sexton; Debbie L Hay Journal: Cell Discov Date: 2016-05-17 Impact factor: 10.849